alpha 1-Antitrypsin (alpha 1 AT) is plasma glycoprotein that constitutes the principle inhibitor of neutrophil elastase in tissue fluids. It has been considered a prototype for liverderived acute phase proteins in that its concentration in plasma increases three-to fourfold during the host response to inflammation/tissue injury. However, recent studies have shown that alpha 1 AT is expressed in several types of extrahepatic cells, including mononuclear phagocytes and enterocytes, and that there are distinct transcriptional units used in hepatocytes and at least one extra-hepatic cell type, blood monocytes. In this study, we have used a combination of ribonuclease protection assays, primer elongation analysis, and transcriptional run-on assays to further characterize mechanisms of basal and modulated alpha 1 AT gene expression in hepatocytes, enterocytes, and macrophages. The hepatoma cell line HepG2, intestinal epithelial cell line Caco2, and primary cultures of human peripheral blood monocytes were used as examples of the cell types. The results indicate that there are three macrophage-specific transcriptional initiation sites upstream from a single hepatocyte-specific transcriptional initiation site. Macrophages use these sites during basal and modulated expression. Hepatoma cells use the hepatocyte-specific transcriptional initiation site during basal and modulated expression but also switch on transcription from the upstream macrophage transcriptional initiation sites during modulation by the acute phase mediator interleukin 6 (IL-6). Caco2 cells use the hepatocyte-specific transcriptional […] 
Introduction a1-Antitrypsin (a, AT) is plasma glycoprotein that constitutes the principle inhibitor of neutrophil elastase in tissue fluids. It has been considered a prototype for liver-derived acute phase proteins in that its concentration in plasma increases three-to fourfold during the host response to inflammation/tissue injury. However, recent studies have shown that a, AT is expressed in several types ofextrahepatic cells, including mononuclear phagocytes and enterocytes, and that there are distinct transcriptional units used in hepatocytes and at least one extrahepatic cell type, blood monocytes. In this study, we have used a combination ofribonuclease protection assays, primer elongation analysis, and transcriptional run-on assays to further characterize mechanisms of basal and modulated a, AT gene expression in hepatocytes, enterocytes, and macrophages. The hepatoma cell line HepG2, intestinal epithelial cell line Caco2, and primary cultures of human peripheral blood monocytes were used as examples of the cell types. The results indicate that there are three macrophage-specific transcriptional initiation sites upstream from a single hepatocyte-specific transcriptional initiation site. Macrophages use these sites during basal and modulated expression. Hepatoma cells use the hepatocytespecific transcriptional initiation site during basal and modulated expression but also switch on transcription from the upstream macrophage transcriptional initiation sites during modulation by the acute phase mediator interleukin 6 . Caco2 cells use the hepatocyte-specific transcriptional initiation site during basal expression. There is a marked increase in the use of this site and an increase in the rate of transcriptional elongation of a, AT mRNA during differentiation of Caco2 cells from crypt-type to villous-type enterocytes. Caco2 cells also switch on transcription from the upstream macrophage transcriptional initiation sites during modulation by . These results provide further evidence that there are differences in the mechanisms of constitutive and regulated expression of the a, AT gene in at least three different cell types, HepG2-derived hepatocytes, Caco2-derived enterocytes and mononuclear phagocytes. (J. Clin. Invest. 1992 . 89:1214-1222.) Key words: acute phase proteins* hepatocytes -mononuclear phagocytes * enterocytes a1 Antitrypsin (a1 AT)' is the archetype of a family of plasma proteins that are called serpins because many of the members are serine protease inhibitors. As shown by the consequences of deficiencies in specific serpins, these proteins play important roles in control of blood-borne limited proteolytic cascade systems (complement, coagulation, fibrinolysis), in control of connective tissue turnover, in limiting tissue destruction and initiating tissue repair at sites of injury/inflammation (reviewed in 1, 2) . Many ofthe serpins are also called "acute phase reactants" in that there are marked increases in their plasma concentrations during the host response to inflammation (reviewed in 3).
For these reasons, there has been a great interest in understanding the mechanisms that determine the net concentrations of serpins in tissues and body fluids. There is still relatively little information about the clearance and catabolism of serpins but more is known about biosynthesis both during basal and regulated states. For a1I AT, liver is the predominant site of synthesis (4, 5) . In this site, synthesis of a1 AT is modulated by the acute phase mediator IL-6 (6) (7) (8) . a1 AT is also synthesized in mononuclear phagocytes (9, 10) . In these cells its synthesis is modulated by bacterial lipopolysaccharide (LPS) and IL-6 (8, 1 1). In both hepatocytes and macrophages synthesis of al AT is modulated by a1 AT-protease complexes as a part ofa feed-forward servomechanism (reviewed in 2). Studies in transgenic mice have suggested that a1 AT is also synthesized in other extrahepatic cell types including renal tubular epithelial cells, intestinal epithelial cells, nonparietal cells of the gastric mucosa, and pancreatic islet cells among others (12) (13) (14) . In fact, we have shown that a1I AT is synthesized in a human enterocyte-like cell line and that its expression in this cell line increases markedly during differentiation from crypt-like to villous-like enterocytes (15 (13, 22) . In this study we (29) for hybridization with 32P-labeled DNA probes.
Ribonuclease protection assays. Specific DNA probes were subcloned into the pGEM4z plasmid and a previously described protocol used (30). After linearization 32P-labeled RNA probes complementary to sense strands were synthesized using linearized plasmid (5 tg), [32p]_ CTP (50 AQCi) and T7 or SP6 RNA polymerase. From this reaction mixture, 1/1,000 of the final product was allowed to hybridize overnight to 10 Ig total cellular RNA in 50% formamide at 550C. RNAse digestion was performed at room temperature with RNAse A and Tl and the protected fragments separated on 6% polyacrylamide gels. The size of each protected fragment was determined by its migration relative to a dideoxy sequencing reaction.
Primer extension analysis. Oligonucleotides were end-labeled with
[32P]ATP, allowed to hybridize overnight with 20 Mg total cellular RNA and subjected to primer extension as previously described (31) . The exon IA oligo was complementary to the sequence of the DNA region around the macrophage specific a1 AT cap site (22) +28 to +58 (5'-AGGCAGCAGCACAGGCCTGCCAGCAGGAG-GATG-3'). The length of each primer extension product was determined by its migration relative to a dideoxy sequencing reaction on 6% polyacrylamide gels. Isolation of nuclei and transcriptional elongation assays. Caco2 cells were scraped into phosphate-buffered saline with a rubber policeman and then pelleted by centrifugation. Cells were homogenized in a loosely fitting Dounce homogenizer in chilled 0.32 M sucrose, 3 mM MgCI2, I mM Hepes (pH 6.8) at a concentration of -1 g of cells/ml. This homogenate was subjected to sucrose density gradient centrifugation as previously described (32) . For transcriptional elongation assays, the nuclei were thawed and resuspended in 200 Ml 18% glycerol, 10mM Tris (pH 7.6), 5 mM MgCl2, 1 mM MnC12, 0.1% beta-mercaptoethanol, 0.4 mM ATP, 0.4 mM CTP, 0.4 mM GTP and 1 mCi/ml [32p]_ UTP. After a 15 min incubation at 37°C, nuclei were digested with RNAse-free DNAse I for 5 min at 37°C. Nuclear RNA was then isolated exactly as described above. Radiolabeled nuclear RNA was hybridized at 37°C for 72 h with DNA blots. DNA blots were prepared by subjecting appropriately digested plasmid DNA constructs to nondenaturing agarose gel electrophoresis. Gels were subjected to alkali denaturation and neutralization and then the DNA was transferred to nitrocellulose filters. Filters were prehybridized at 37°C for 24 h. After hybridization the filters were washed in 2x SSC/0.1% SDS at room temperature for 10 min and then at 56°C for 10 min. Results were quantified by densitometric scanning ofautoradiograms on a laser densitometer (2222 Ultrascan XL; LKB Instruments, Inc., Houston, TX).
Results
Different transcriptional initiation sites for a, AT (22) .
It also has 39 bases of vector sequence. Probe B is a 170-base pair EcoRI-PstI fragment from the 5'-terminus of macrophage cDNA clone L17.3 (22) . It also has 24 bases of vector sequence. Probe C is a 158-base pair BamHI-BamHI fragment derived from L17.3 and spanning the hepatocyte-specific aI AT cap site. It also has 60 bases of vector sequence. A map of the probes is shown at the top and the relative electrophoretic migration of the probe, which was different for each of the three autoradiograms, is shown at the left margin. The size of each protected fragment, as determined by its migration relative to a sequencing ladder, is indicated by arrows at the left margin of each panel. The autoradiogram with probe C was exposed to its gel for only 2 h as compared to 6 h for those with probes A and B.
158-nucleotide BamHI-BamHI fragment from cDNA clone L17.3 and spans the previously described hepatocyte-specific transcriptional initiation site (22) .
Probe A protects two fragments in monocytes and therefore indicates that there are two transcriptional initiation sites with exon IA. This confirms our previous results (22) . There is a modest increase in the levels of these fragments induced by LPS. The same two fragments were also identified in control and LPS-activated human bronchoalveolar macrophages (data not shown). These fragments are specific as shown by their absence in tRNA, undifferentiated (day 1) and differentiated (day 15) Caco2 cells and control HepG2 cells. These two fragments are present at low levels in HepG2 cells that have been incubated with IL-6. This is more easily seen on longer autoradiographic exposure ofthis gel as well as in gels from four other experiments (data not shown).
Probe B also protects two fragments in monocytes. The larger fragment is fully protected, and therefore represents the two transcripts that have started upstream from exon IA. The smaller fragment must therefore represent a unique transcriptional initiation site for aI AT mRNA upstream from exon MB.
Based on these studies and primer extension analysis (see below) we have mapped this initiation site to within several nucleotides of position -1892 relative to the hepatocyte transcriptional initiation site (according to the sequence of Long et al. [33] ). There is an increase in the level of each of these fragments during modulation by LPS. These fragments are not detected in undifferentiated or differentiated Caco2 cells and are not detected in control HepG2 cells but are induced in HepG2 cells treated with IL-6.
Probe C, which overlaps the so-called hepatocyte transcription initiation site in exon IC, protects one fragment in monocytes. This fragment is fully protected, and therefore, represents the transcripts which have started upstream in exons IA and IB. There is an increase in the level of this fragment induced by LPS. A smaller fragment is present in Caco2 cells and HepG2 cells. This, therefore, represents use of the hepatocytespecific transcriptional initiation site within exon IC. There is a marked increase in the level ofthis fragment during differentiation of Caco2 cells. There is a lesser increase in the level of this fragment in IL-6-treated HepG2 cells. These results indicate that there are three macrophage-specific transcriptional initiation sites and one hepatocyte-specific initiation site. There is an increase in the use of the cell-specific transcriptional initiation sites for each cell type, monocytes and hepatocytes, during modulated expression. There is also a switch to induce transcription from the upstream macrophage-specific initiation sites in HepG2 cells activated by IL-6. Caco2 cells use the hepatocyte transcriptional initiation site excusively for basal expression as well as during the marked increase in expression that accompanies their differentiation.
We next examined the effect of a single mediator, IL-6, on a I AT mRNA transcriptional initiation sites in the three different cell types (Fig. 2) . (Fig. 1) the downstream transcriptional initiation site during basal and modulated expression but also switch on transcription at lower levels from the upstream initiation sites during expression modulated by IL-6. Our interpretation of these results was consistent with results of previous primer extension analysis (22) as well as additional primer extension studies performed here: two primer extension products were detected in monocytes with the exon IA oligo; three primer extension products were detected in monocytes with the exon IB oligo; and one primer extension product was detected in hepatocytes and enterocytes by the exon IC oligo (data not shown). Our interpretation of these results was also confirmed by results of RNA blot analysis (Fig.  3) . Using probe A, which spans the macrophage-specific transcriptional start sites within exon IA a single -2.0 kb RNA is detected in monocytes but not in Caco2 cells or HepG2 cells. There is a modest increase in the level ofthis mRNA in monocytes incubated with LPS and the magnitude of this increase is similar to that detected by ribonuclease protection assay. Using probe D, a macrophage cDNA probe (22) which extends from the 3' terminus ofprobe A into the 3' untranslated region ofthe a, AT mRNA, a 1.6 kb mRNA is detected in Caco2 cells and HepG2 cells. There is a modest increase in the level of this mRNA in HepG2 cells incubated with IL-6. Two mRNAs that are larger in apparent molecular mass, 1.8 and 2.0 kb, are detected in LPS-treated monocytes. Both of these mRNAs are also seen in control monocytes with longer autoradiographic exposure times (data not shown). Using probe E, a hepatocyte cDNA probe (25) , which extends from the hepatocyte transcription initiation site to the 3'-terminus of the a, AT Fig. 3 . Finally, start of transcription within exon IB results in a 1.8-kb a, AT mRNA 4. a, AT mRNAs 2, 3, and 4 are found in monocytes and their levels increase in LPS-and IL-6-activated monocytes. These three mRNA species are also induced in HepG2 cells and differentiated Caco2 cells by . The level of these three mRNA species in IL-6-activated HepG2 cells and IL-6-activated Caco2 cells just reaches the limits of sensitivity of ribonuclease protection assays (Figs. 1 and 2 ) but does not reach the limits of sensitivity of RNA blot analysis (Fig. 3) .
The increase in a, AT Figure 3 . RNA blot analysis to determine the relative electrophoretic migration of a, AT mRNA in different cell types. Total cellular RNA was isolated exactly as described in the legend for Fig. 1 and 15 ,gs was subjected to RNA blot analysis as described in Methods. The relative electrophoretic migration of ethidium bromide-stained 18S ribosomal RNA is indicated at the right margin and that of a, AT mRNA species at the left margin. The relative amounts ofa1 AT mRNA in monocytes cannot be compared to that of Caco2 cells or HepG2 cells since longer autoradiographic exposure was necessary for the blot with probe A and for lanes 4 and 5 with probes D and E. A map ofthe probes is shown at the top ofthe figure. vious study we have shown that there is an increase in steady state levels of a1 AT mRNA in Caco2 cells during the time interval from day 1 to day 16 after the cells have become confluent, a time interval that is associated with differentiation from crypt-like to villous-like enterocytes by both morphological and biochemical criteria (15) . Ribonuclease protection assays in the current study have confirmed these previous results and have demonstrated that the hepatocyte-specific transcriptional initiation site is used for basal expression as well as for the marked increase in expression of the a1 AT gene during differentiation of Caco2 cells (Fig. 1) . In order to determine whether this increase was caused by an increase in rate oftranscription and/or a decrease in rate of a1 AT mRNA turnover we examined the rate of a1 AT mRNA transcriptional elongation during differentiation of Caco2 cells (Fig. 5 ). Nuclei were isolated on days 1 and 12, after the cells had reached confluence and allowed to incorporate [32P]UTP. The resulting radiolabeled nuclear RNA was hybridized to an aI AT cDNA probe as well as to several control cDNA probes on DNA blots. The results demonstrate hybridization to aI AT cDNA but not to negative control albumin cDNA and not to either plasmid pGEM4z or pKT2 18 . There is also a marked increase in speMap of aAT mRNAs cific a1 AT mRNA transcriptional elongation by day 12 in culture ( Fig. 5 a) . Results of three separate experiments indicate that there is a 6.7-±1.3-fold increase in a1 AT mRNA transcription and that the increase is specific, in that there is no change in a control, ubiquitin mRNA transcription (Fig. 5 b) . Thus the increase in a1 AT mRNA levels during differentiation of Caco2 cells is due, at least in large part, to an increase in a1 AT gene transcription. Finally, we examined the possibility that this increase in ai AT mRNA transcription during differentiation of Caco2 cells into villous-like enterocytes was reflected by the distribution of a1 AT gene expression within human intestine. Total cellular RNA from human jejunum and colon was subjected to ribonuclease protection assays (Fig. 6 ) with probe C from Fig. 1 to govern translation. GCN4 encodes a nuclear transcription factor necessary for the expression of amino acid biosynthetic enzymes in response to amino acid starvation. Removal of the initiation codons of four short open-reading frames upstream from the GCN4 gene by deletions or point mutations leads to constitutive derepression of GCN4 by allowing translation (34, 36) . It is now thought that these structures can repress GCN4 expression under nonstarvation conditions by acting as initiation sites during ribosomal scanning, allowing for only inefficient reinitiation at the downstream internal initiation codon. During amino acid starvation, two transacting nuclear proteins, GCD1 and GCN2, interfere with the interaction of the ribosomes and the upstream initiation sites, allowing for more efficient initiation at the "true" internal initiation codon. Our current studies were, in part, stimulated by the analogy between GCN4 and a, AT with respect to these upstream structures but also by the fact that the increase in a1I AT gene expression in macrophages mediated by the prototype macrophage inflammatory activator LPS involves a marked increase in the efficiency of translation of a, AT mRNA (37) : LPS mediates a marked increase in synthesis of a1 AT (5-to 10-fold) in blood monocytes and bronchoalveolar macrophages but much less impressive increase in steady state levels of a, AT mRNA (1.5-to 2.5-fold); moreover, there is a 4-to 5-fold increase in cell-free synthesis of al AT directed by RNA from LPS-activated monocytes as compared to that from control monocytes. With the regulation of GCN4 during amino acid starvation in mind, we therefore predicted that the translational effect of LPS would be associated with an increase in a, AT mRNA transcripts initiated at the downstream hepatocyte-specific initiation site. A direct examination of this prediction in the current study shows that there is absolutely no initiation at the hepatocyte al AT promoter in LPS-activated monocytes. There are several possible alternative explanations for the translational effect of LPS on a, AT gene expression. For example, it is possible that a "slowing" ofribosomal scanning in some cases, as might occur during initiation and termination at upstream codons, has an enhancing effect on recognition of the downstream initiation codon and thereby facilitates translation (38, 39) . Specific RNA-protein interactions and changes in RNA folding are alternative possible explanations for the translational effect of LPS on a I AT gene expression. In fact, formation of stem loop structures in the upstream flanking region is now thought to be an important prerequisite for translational regulation of the transferrin receptor gene in response to iron (40, 41) and that of the ornithine decarboxylase gene in response to hormones (42) .
We have subjected the macrophage a, AT mRNAs to analysis by a computer program for folding of RNA molecules (43) . This analysis shows that the macrophage al AT mRNAs form very stable secondary structures with at least four stem-loop configurations but does not provide an obvious explanation for the translational effect of LPS on macrophage a, AT gene expression.
In this study we also mapped the transcriptional initiation sites for basal and modulated expression of the a, AT gene in human hepatoma cells. We were particularly interested in the effect of IL-6 which is known to mediate an -2.5-to 3.5-fold increase in a, AT mRNA levels and in synthesis of a, AT (6, 8 In a human intestinal epithelial cell line, Caco2, the hepatocyte a1 AT promoter is used for basal expression. There is a marked increase in a, AT mRNA levels and a corresponding increase in synthesis and secretion of a, AT during differentiation of this cell line into a villous-like enterocyte (15) . This increase is, at least in large part, explained by an increase in the rate of transcription and resulting transcripts originate exclusively from the hepatocyte promoter. The distribution ofthese a, AT transcripts in human jejunum but not in human colon may reflect the effect on this gene of differentiation towards the villous cell lineage as contrasted to the crypt cell lineage. This differentiation-dependent increase in Caco2 cell a, AT gene expression could also represent a recapitulation of late fetal development as has been suggested for the expression ofa-fetoprotein in this cell line (46) . Finally expression of a1I AT in differentiated Caco2 cells may be further modulated by soluble mediators such as IL-6. In this case there is an increase in transcription from the downstream hepatocyte promoter but IL-6-activated Caco2 cells also induce transcripts originating from the upstream initiation sites in a manner similar to that of IL-6-activated HepG2 cells.
